3-D Matrix (7777) Fundamentals 2026 — P/E 9.8x, Revenue Analysis | SniperIQ
3-D Matrix (7777) is a JP-listed Healthcare company in Medical - Devices with a market capitalization of ¥41.1B, trading at ¥342.00 on the JPX. This SniperIQ fundamentals page covers 3-D Matrix's valuation (P/E 9.8x, P/B 6.2x), profitability (net margin 38.2%), revenue (¥10.9B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is 3-D Matrix's market cap?
3-D Matrix (7777) has a market capitalization of approximately ¥41.1B, trading at ¥342.00 on the JPX. Market cap moves with the live share price.
What is 3-D Matrix's P/E ratio?
3-D Matrix's trailing twelve-month P/E ratio is 9.8x, with a price-to-book (P/B) of 6.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is 3-D Matrix?
3-D Matrix runs a net profit margin of 38.2%, a gross margin of 78.7%, and an operating margin of 12.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does 3-D Matrix generate?
3-D Matrix reported revenue of ¥10.9B for fiscal year 2026, with net income of ¥4.2B and earnings per share (EPS) of 34.89. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does 3-D Matrix pay a dividend?
3-D Matrix does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is 3-D Matrix financially healthy?
3-D Matrix carries a debt-to-equity ratio of 0.09x and a current ratio of 3.11x, with a market beta of 0.99. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is 3-D Matrix a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For 3-D Matrix (7777) the key facts are: market cap ¥41.1B, P/E 9.8x, revenue ¥10.9B, 52-week range 195-793. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track 3-D Matrix's full fundamentals live
Get 3-D Matrix's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.